Oncology News
- Is ChatGPT a Friend or Foe of Medical Publishing?
- ASCO 2023 First or Second-Line CDK4/6 Inhibition in Breast Cancer?
- Sequencing Strategy in Ovarian Cancer Helps Guide Treatment
- Metronomic Therapy Effective in Head and Neck Cancer
- ASCO 2023 PMBCL: Postremission, Patients May Safely Skip Radiation
- Widespread Carboplatin, Cisplatin Shortages: NCCN Survey
- Palliative Care Laws Make a Difference for Cancer Patients
- Cognitive Decline Risk in Adult Childhood Cancer Survivors
- Risk of Falls With Newer Antiandrogens for Prostate Cancer
- ASCO 2023 Huge Underuse of Germline Testing for Cancer Patients
- ASCO 2023 CAR T-Cell Benefit in Lenalidomide-Refractory Myeloma
- ASCO 2023 T-DXd Active in Many Solid Tumors; 'Shift in Thinking'
- ASCO 2023 Safe to Stop Immunotherapy at 2 Years in Stable Lung Cancer
- When Could You Be Sued for AI Malpractice? You're Likely Using It Now
- New CLL Meds: Improved Survival Rates, 1990–2018
- ASCO 2023 Antibody-Drug Conjugate MIRV Improves OS in Ovarian Cancer
- ASCO 2023 Chemo Avoidance Pays Off for Some Women With HER2+ Early BC
- ASCO 2023 Groundbreaking New Regimen for Advanced Hodgkin Lymphoma
- ASCO 2023 Meta-Analysis Supports Ovarian Suppression in Breast Cancer
- ASCO 2023 Reconnecting With Patients to 'Rediscover Joy of Oncology'